Abstract
Cross presentation is the process of production of peptide-MHC Class I complexes by cells in which the antigen that is the source of peptide is not translated. The majority of recent studies have described many facets of the classical TAP-dependent cross presentation pathway, but numerous pathways for transfer of antigenic material from a donor to a recipient cell followed by subsequent MHC-I-restricted presentation have been established, including transfer of protein antigen, peptide, RNA, DNA or even peptide-MHC-I complexes. The extent to which each of these pathways generates overlapping or unique peptide repertoires is unknown, as is the contribution of each of these pathways to generation of protective CD8+ T cells during infection or anti-tumor immune responses.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 110-116 |
| Number of pages | 7 |
| Journal | Current Opinion in Immunology |
| Volume | 40 |
| DOIs | |
| State | Published - Jun 1 2016 |
All Science Journal Classification (ASJC) codes
- Immunology and Allergy
- Immunology
Fingerprint
Dive into the research topics of 'Defining cross presentation for a wider audience'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver